text-size: + - R
JB Slider

Top News Stories

  • New Eczema Drug ApprovedThe FDA recently approved a novel drug, crisaborole (Eucrisa), for the treatment of mild to moderate AD in adults and children greater than the age of two. This topical ointment is a phosphodiesterase...Read More
  • New Testosterone WarningsThe FDA recently approved label changes for all testosterone products to reflect new warnings of abuse and dependency. Prescribers will now be alerted by this new warning of potential abuse, adverse ...Read More
  • The Soaring Price of Epi-PenThe EpiPen® is a potential life-saving medication for patients who experience severe allergic reactions. The drug recently and dramatically spiked in price, drawing considerable national attention...Read More
  • Loperamide Cardiac Toxicity Opioid abuse continues to be problematic throughout the United States, and many medical providers are limiting opioid prescribing. While the intent is to limit opioid abuse by limiting supply, it has ...Read More
  • New Labeling for FluoroquinolonesThe Food and Drug Administration recently strengthened warning labels on fluoroquinolone antibiotics to address the serious risks associated with using these antibiotics for minor infections. A review...Read More
  • Nation's Emergency Physicians ID Insurance Industry as Co-Culprits in High Drug Prices WASHINGTON,  In response to a recent rash of news stories reporting spikes in price for both generic and name-brand pharmaceutical drugs, the president of the American College of Emergency ...Read More
  • New Warnings for SGLT-2 InhibitorsSodium-glucose co-transporter 2 (SGLT-2) inhibitors have been available for treatment of type 2 diabetes mellitus in the United States since early 2013. Drugs in this class include canagliflozin (...Read More
Pill Identification Tool

Health Topics

View More Topics »